Paul Hartmann AGSTU:PHH2 62 Market Cap is €728 Mil as of Jul. 04, 2026. GuruFocus rates STU:PHH2 with a GF Score™ of 62/100 and a GF Value™ of €229.60 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 868 Medical Devices & Instruments companies, Paul Hartmann AG ranks better than 77.07% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Paul Hartmann AG's share price for the quarter that ended in Dec. 2025 was €227. Paul Hartmann AG's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 4 Mil. Therefore, Paul Hartmann AG's market cap for the quarter that ended in Dec. 2025 was €806 Mil.
Paul Hartmann AG's quarterly market cap
increased
from Dec. 2024 (€781 Mil) to Jun. 2025 (€860 Mil) but then
declined
from Jun. 2025 (€860 Mil) to Dec. 2025 (€806 Mil).
Paul Hartmann AG's annual market cap
increased
from Dec. 2023 (€725 Mil) to Dec. 2024 (€781 Mil) and
increased
from Dec. 2024 (€781 Mil) to Dec. 2025 (€806 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Paul Hartmann AG's Enterprise Value for Today is €970 Mil.
Paul Hartmann AG (STU:PHH2) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Paul Hartmann AG Market Cap Related Terms
Paul Hartmann AG Market Cap Historical Data
* Premium members only.
The historical data trend for Paul Hartmann AG's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:PHH2 vs ISRG, BDX, MDLN: Market Cap Comparison
For the Medical Instruments & Supplies subindustry, Paul Hartmann AG's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Paul Hartmann AG Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Paul Hartmann AG's Market Cap distribution charts can be found below:
* The bar in red indicates where Paul Hartmann AG's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Paul Hartmann AG's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Paul Hartmann AG (STU:PHH2) has a Market Cap of €728 Mil as of Jul. 04, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Paul Hartmann AG and its competitors. According to the industry distribution chart, Paul Hartmann AG ranks #199 out of 868 companies in the Medical Devices & Instruments industry, placing it in the top 22.9%.
Is Paul Hartmann AG's Market Cap too high?
Paul Hartmann AG's current Market Cap is €728 Mil. Based on the distribution chart, Paul Hartmann AG ranks #199 out of 868 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Paul Hartmann AG has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Paul Hartmann AG's Market Cap compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Paul Hartmann AG ranks #199 out of 868 companies for Market Cap. This places Paul Hartmann AG in the top 23% of its industry — outperforming the majority of peers. The industry median Market Cap is 122.08. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 122.08, based on 868 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Paul Hartmann AG and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 122.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Paul Hartmann AG's current Market Cap is €728 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Paul Hartmann AG stock overvalued right now?
Based on GuruFocus' analysis, Paul Hartmann AG (STU:PHH2) is currently considered Modestly Undervalued. The stock's GF Value™ is €229.60, compared to a current price of €204.00 — trading 11.1% below its estimated fair value. The current Market Cap is €728 Mil. Paul Hartmann AG's overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Paul Hartmann AG (STU:PHH2), the current Market Cap is €728 Mil as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Paul Hartmann AG (STU:PHH2) Overvalued in 2026?
Based on GuruFocus' analysis, Paul Hartmann AG stock appears to be undervalued.
The current stock price of €204.00 is trading 11.1% below its estimated GF Value™ of €229.60.
GuruFocus considers Paul Hartmann AG to be Modestly Undervalued.
Key valuation signals for STU:PHH2:
Market Cap: €728 Mil
GF Value™: €229.60 vs. price of €204.00 (11.1% below fair value)
No single metric tells the full story. See the STU:PHH2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Paul Hartmann AG engages in the production of medical and hygiene products. It operates through Wound Management, Incontinence Management and Infection Management and other segments. The Wound segment comprises wound dressing and treatment, compression therapy, first aid, immobilization, and diagnostics. The Incontinence segment provides incontinence hygiene, patient care, and medical skin care. The Infection segment consists of custom procedure trays, surgical draping systems, disposable surgical instruments, and disinfectants. The Other activities include activities in cotton-wool products, medical consumer goods and pharmaceutical products and others. All the activities are functioned through the region of US and derive revenue through the sale of medical and hygiene products.
62GF Score
Get the complete analysis for STU:PHH2
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:PHH2 has been successfully added to your 
